BioGaia AB (publ)
BioGaia AB (publ), a healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand. It operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well … Read more
BioGaia AB (publ) (BIOG-B) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.090x
Based on the latest financial reports, BioGaia AB (publ) (BIOG-B) has a cash flow conversion efficiency ratio of 0.090x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr110.15 Million) by net assets (Skr1.22 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
BioGaia AB (publ) - Cash Flow Conversion Efficiency Trend (2002–2024)
This chart illustrates how BioGaia AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
BioGaia AB (publ) Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of BioGaia AB (publ) ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
GQG PARTNERS CDI/1/1
F:6P1
|
N/A |
|
Zhejiang Zhaolong Interconnect Technology Co. Limited
SHE:300913
|
0.062x |
|
Xiangyang Changyuan Donggu Industry Co Ltd
SHG:603950
|
0.023x |
|
Beijing Join-Cheer Software Co Ltd
SHE:002279
|
0.067x |
|
BYTES TECH.GRP LS -01
F:9NY
|
N/A |
|
Ta Ya Electric Wire & Cable Co., Ltd.
TW:1609
|
-0.016x |
|
GRAY TELEVISION A DL-01
F:GCZA
|
N/A |
|
Nanosonics Limited
PINK:NNCSF
|
0.109x |
Annual Cash Flow Conversion Efficiency for BioGaia AB (publ) (2002–2024)
The table below shows the annual cash flow conversion efficiency of BioGaia AB (publ) from 2002 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Skr1.72 Billion | Skr373.22 Million | 0.216x | +3.19% |
| 2023-12-31 | Skr2.03 Billion | Skr425.96 Million | 0.210x | +29.74% |
| 2022-12-31 | Skr1.97 Billion | Skr318.94 Million | 0.162x | +36.82% |
| 2021-12-31 | Skr1.88 Billion | Skr221.88 Million | 0.118x | -6.72% |
| 2020-12-31 | Skr1.75 Billion | Skr221.26 Million | 0.127x | -56.48% |
| 2019-12-31 | Skr507.87 Million | Skr147.85 Million | 0.291x | -19.22% |
| 2018-12-31 | Skr508.12 Million | Skr183.12 Million | 0.360x | -24.90% |
| 2017-12-31 | Skr463.89 Million | Skr222.62 Million | 0.480x | +34.69% |
| 2016-12-31 | Skr415.18 Million | Skr147.93 Million | 0.356x | +20.03% |
| 2015-12-31 | Skr395.83 Million | Skr117.50 Million | 0.297x | -17.76% |
| 2014-12-31 | Skr344.59 Million | Skr124.38 Million | 0.361x | +45.81% |
| 2013-12-31 | Skr316.86 Million | Skr78.44 Million | 0.248x | -66.30% |
| 2012-12-31 | Skr456.79 Million | Skr335.56 Million | 0.735x | +132.47% |
| 2011-12-31 | Skr230.35 Million | Skr72.79 Million | 0.316x | -14.17% |
| 2010-12-31 | Skr187.32 Million | Skr68.97 Million | 0.368x | +11.31% |
| 2009-12-31 | Skr161.12 Million | Skr53.29 Million | 0.331x | +128.07% |
| 2008-12-31 | Skr132.42 Million | Skr19.20 Million | 0.145x | +170.52% |
| 2007-12-31 | Skr94.91 Million | Skr5.09 Million | 0.054x | +580.80% |
| 2006-12-31 | Skr74.53 Million | Skr-831.00K | -0.011x | +91.97% |
| 2005-12-31 | Skr71.78 Million | Skr-9.97 Million | -0.139x | -155.28% |
| 2004-12-31 | Skr91.50 Million | Skr22.99 Million | 0.251x | +27.74% |
| 2003-12-31 | Skr114.85 Million | Skr22.59 Million | 0.197x | -14.88% |
| 2002-12-31 | Skr127.99 Million | Skr29.57 Million | 0.231x | -- |